surmount 5 tirzepatide SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Improved health‐related quality of life

These medications are generally recommended for individuals who are overweight or obese, especially if they have additional health risks like type 2 diabetes or metabolic syndrome

Every time your heart beats, it pushes blood into blood vessels around the heart, which are called arteries

High plasma levels of LDL, remnants and possibly Lp(a) promote accumulation of inflammatory cells, including foam cells, enhancing atherosclerotic plaque formation

Design your growth-peptide protocol Talk to a provider about whether Tesamorelin, CJC-1295, or a combination fits your goals and how to run it safely

Journal of Thoracic and Cardiovascular Surgery 169: e18, 2025

In compliance with the JTI standards More: SWI swissinfo.ch certified by the Journalism Trust Initiative You can find an overview of ongoing debates with our journalists here